Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.13.11.34 extracted from

  • Abe, M.; Ozawa, Y.; Uda, Y.; Morimitsu, Y.; Nakamura, Y.; Osawa, T.
    A novel labdane-type trialdehyde from myoga (Zingiber mioga Roscoe) that potently inhibits human platelet aggregation and human 5-lipoxygenase (2006), Biosci. Biotechnol. Biochem., 70, 2494-2500.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
miogadial potent inhibitor, IC50: 0.004 mM Homo sapiens
miogatrial potent inhibitor, IC50: 0.0075 mM Homo sapiens
additional information no inhibition by galanal A, galanal B and 8beta(17)-epoxy-15-hydroxy-12(E)-labden-16-al Homo sapiens
polygodial strong inhibitory activity, IC50: 0.0086 mM Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
blood platelet
-
Homo sapiens
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
arachidonate + O2
-
Homo sapiens (6E,8Z,11Z,14Z)-(5S)-hydroperoxyicosa-6,8,11,14-tetraenoate
-
?

Synonyms

Synonyms Comment Organism
5-LOX
-
Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.004
-
potent inhibitor, IC50: 0.004 mM Homo sapiens miogadial
0.0075
-
potent inhibitor, IC50: 0.0075 mM Homo sapiens miogatrial
0.0086
-
strong inhibitory activity, IC50: 0.0086 mM Homo sapiens polygodial